Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists like semaglutide have transformed weight loss treatment, but patients often wonder how long they should remain on therapy. Clinical trials show that sustained semaglutide use over 12 to 24 months produces the greatest weight loss and metabolic improvements, with discontinuation often leading to weight regain within months.
Typical Duration of Semaglutide Treatment for Weight Loss
Most patients starting semaglutide can expect an initial treatment window of 12 to 24 months to achieve their target weight. During the first 4 to 8 weeks, your body adjusts to the medication while appetite suppression begins. The most significant weight loss typically occurs between months 3 and 9, when the full appetite-reducing and metabolic effects become established.
The exact timeline depends on your starting weight, metabolic rate, lifestyle changes, and individual response to the medication. Some patients reach their goals in 6 months, while others benefit from extended therapy. PlexusDx providers help track your progress monthly and adjust treatment plans based on your real-world results, ensuring you stay on track without unnecessary delays.
Why Long-Term Maintenance Therapy Often Works Best
Research from clinical trials demonstrates that patients who discontinue semaglutide after achieving weight loss often regain 50% or more of their lost weight within one year. This occurs because the medication addresses appetite regulation and metabolic drive—processes that reactivate once treatment stops. For this reason, many healthcare providers now recommend maintenance therapy at a stable dose to prevent rebound weight gain.
Maintenance semaglutide therapy typically involves staying on your effective dose indefinitely, much like managing blood pressure or cholesterol long-term. Your PlexusDx provider can help determine whether maintenance therapy aligns with your goals and health status. The Precision Peptide Genetic Test can reveal your GLP1R and other peptide-pathway variants, which may predict how well you'll respond to long-term semaglutide therapy and whether dose adjustments could improve outcomes.
When to Adjust Your Semaglutide Duration and Dosing
Your dose may need to go up—your price won't. PlexusDx pricing remains flat at $149 per month regardless of dose adjustments, allowing your provider to optimize your therapy without cost increases. If you plateau in weight loss after 8 to 12 weeks at your current dose, an increase often restarts progress. Conversely, if you experience bothersome side effects, dose reduction or a temporary pause can help you tolerate the medication better.
Reassessing your treatment plan every 4 to 8 weeks ensures you're on the right path. Some patients benefit from cycling between active treatment and maintenance phases, while others do best on consistent, uninterrupted therapy. Your PlexusDx provider reviews your monthly progress, hunger levels, energy, and any side effects to tailor the duration and intensity of your semaglutide protocol to your unique needs.
Compounded Semaglutide vs. Brand-Name Wegovy: What's the Difference?
PlexusDx compounded semaglutide injection comes from licensed 503A compounding pharmacies and offers the same active ingredient as brand-name Wegovy, but at a lower cost and without membership fees or insurance requirements. Both require the same duration and commitment—typically 6 to 24 months of active treatment followed by long-term maintenance. The key difference is accessibility and affordability: PlexusDx semaglutide starts at $149 per month and is HSA/FSA eligible, making extended therapy more sustainable for most patients.
Whether you choose compounded or brand-name semaglutide, the clinical timeline remains the same: expect results over months, not weeks. PlexusDx also offers oral semaglutide for patients who prefer injections-free therapy, starting at $249 per month. Regardless of format, your provider will guide you on how long to stay on therapy based on your response, side effect tolerance, and long-term weight maintenance goals.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I stop semaglutide after reaching my weight loss goal?
While you can stop, clinical evidence shows most patients regain significant weight within 12 months after discontinuation. Many providers now recommend long-term maintenance therapy at a stable dose to prevent rebound weight gain. Your PlexusDx provider can discuss whether maintenance or cycling approaches fit your health goals and lifestyle.
What does research say about semaglutide duration?
The STEP trials showed that patients on semaglutide for 56 weeks lost an average of 12–18% of body weight, with continued benefits at week 68. When patients stopped the medication, they regained weight rapidly. Extended therapy (12–24 months or longer) maximizes results and weight stability.
How much does semaglutide cost per month at PlexusDx?
PlexusDx compounded semaglutide injection starts at $149 per month with no membership fees, no insurance required, and HSA/FSA eligibility. Your dose may need to go up—your price won't, ensuring you can adjust treatment without cost surprises.
Are there side effects if I stay on semaglutide long-term?
Most side effects (nausea, fatigue, constipation) decrease after 4–8 weeks as your body adapts. Long-term use is generally well-tolerated, though some patients experience mild ongoing gastrointestinal effects. Your PlexusDx provider monitors you monthly to manage any concerns and adjust your dose if needed.
How can the Precision Peptide Genetic Test help predict my semaglutide response?
PlexusDx maps genetic variants in GLP1R, GIPR, FTO, and MC4R pathways to identify how your body responds to GLP-1 therapy. This $99 add-on test after your first month reveals whether you're a strong responder (likely to benefit long-term) or may need a different approach, helping your provider optimize your treatment duration.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Should You Eat Before Your Wegovy Injection? Essential Insights for Your Weight Loss Journey
How Fast Should You Lose Weight on Zepbound?